| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/11/1990 | EP0362371A1 Il-2 receptor-specific chimeric antibodies |
| 04/11/1990 | EP0362332A1 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 04/11/1990 | EP0362297A1 Hepatic blocking agents |
| 04/11/1990 | EP0362290A1 Cloning of mite allergens |
| 04/11/1990 | EP0362278A1 Autocrine motility factors in cancer diagnosis and management |
| 04/11/1990 | EP0211022B1 Monoclonal antibodies against core proteins of lymphadenopathy-associated-viruses |
| 04/10/1990 | US4916119 Immunostimulant tripeptides |
| 04/10/1990 | US4916070 Fibrin-specific antibodies and method of screening for the antibodies |
| 04/10/1990 | US4915942 Protein of a parasite of genus plasmodium |
| 04/10/1990 | US4915683 Antiviral method, agents and apparatus |
| 04/07/1990 | CA2000263A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells |
| 04/05/1990 | WO1990003576A1 Cell sorting technique and applications thereof |
| 04/05/1990 | WO1990003447A1 Diagnostic test for hblv |
| 04/05/1990 | WO1990003437A1 Proteins for fusing the sub-unit b of the choleraic toxin and heterologous antigen, and nucleic acids encoding them |
| 04/05/1990 | WO1990003433A1 Vaccine |
| 04/05/1990 | WO1990003401A1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages |
| 04/05/1990 | WO1990003400A1 Intercellular adhesion molecules, and their binding ligands |
| 04/05/1990 | WO1990003398A1 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 04/05/1990 | WO1990003396A1 Dna damage-binding factor and uses therefor |
| 04/05/1990 | WO1990003394A2 New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines |
| 04/05/1990 | WO1990003186A1 Gram-negative bacterial endotoxin blocking monoclonal antibodies |
| 04/05/1990 | WO1990003184A1 Matrix with immunomodulating activity |
| 04/05/1990 | WO1990003183A1 Immunotherapy vaccine for melanoma tumors |
| 04/05/1990 | DE3932461A1 Monoklonaler antikoerper gegen ein synthetisches peptid und verfahren zu dessen herstellung A monoclonal antibody against a synthetic peptide and process for its preparation |
| 04/04/1990 | EP0362179A2 Recombinant saccharomyces |
| 04/04/1990 | EP0361902A2 Method for the reduction of heterogeneity of monoclonal antibodies |
| 04/04/1990 | EP0361284A2 T cell growth factor |
| 04/04/1990 | EP0361182A1 Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
| 04/03/1990 | US4914021 Kit for screening colorectal cancer |
| 04/03/1990 | US4913908 Polymerizing alkyl cyanoacrylate in aqueous suspension of biologically active material without surfactant |
| 04/03/1990 | US4913902 Filtration, extraction of purified materials from liposomes |
| 04/03/1990 | CA2000044A1 Monoclonal antibodies against receptor induced binding sites |
| 03/28/1990 | EP0360433A1 Protein derivatives and a process for their preparation |
| 03/28/1990 | EP0359919A2 Recombinant mycoplasma hyopneumoniae antigen and uses therefor |
| 03/28/1990 | EP0105364B1 Temperature sensitive reassortant viruses and a vaccine against equine influenza |
| 03/28/1990 | CN1040820A Chick staphylococcus oil emulsion inactivated killed vacine |
| 03/27/1990 | US4912201 Monoclonal antibodies and antisera to intragonadal regulatory protein |
| 03/27/1990 | US4911918 Oral composition containing stabilized antibody |
| 03/27/1990 | US4911912 Treatment of glycoprotein with periodate and cyanoborohydride |
| 03/27/1990 | US4911911 Treatment of glycoprotein with periodate in presence of amine |
| 03/27/1990 | US4911910 Purified equine immunologlobulins and method of use thereof |
| 03/27/1990 | US4911909 Method of controlling hypertension using monoclonal antibodies to angiotensin-II |
| 03/27/1990 | CA1267087A1 Synthetic immunogen |
| 03/27/1990 | CA1267083A1 Sheet-like diagnostic device |
| 03/27/1990 | CA1267082A1 Carrier material for use in immune determinations |
| 03/22/1990 | WO1990002811A1 A malaria antigen |
| 03/22/1990 | WO1990002803A2 Viral vaccines |
| 03/22/1990 | WO1990002802A2 Viral nucleotide sequences |
| 03/22/1990 | WO1990002762A1 Macrophage-derived inflammatory mediator (mip-2) |
| 03/22/1990 | WO1990002752A1 Allelic variants of plasmodium falciparum merozoite surface antigen |
| 03/22/1990 | WO1990002569A1 Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 03/22/1990 | WO1990002568A1 Hiv-1 envelope muteins lacking hypervariable domains |
| 03/22/1990 | WO1990002567A1 Virus-derived antigenic composition and its preparation and use |
| 03/22/1990 | WO1990002566A1 Fusion protein of paramyxovirus, method of production using recombinant baculovirus expression vector, vaccine comprising such protein and use thereof |
| 03/22/1990 | WO1990002565A1 Swine dysentery subunit vaccine and method |
| 03/22/1990 | WO1990002564A1 Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi |
| 03/22/1990 | WO1990002563A1 Antigens of schistosoma mansoni |
| 03/22/1990 | WO1990002559A1 Pharmaceutical compositions for eliciting an immunostimulant effect |
| 03/22/1990 | WO1990002557A1 Vaccines and diagnostic assays for haemophilus influenzae |
| 03/22/1990 | WO1990002484A1 Oral immunization by transgenic plants |
| 03/21/1990 | EP0359428A1 Protein derivatives and a process for their preparation |
| 03/21/1990 | EP0359347A2 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 03/21/1990 | EP0359282A2 Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic compositions containing same |
| 03/21/1990 | EP0359096A1 Antibodies having modified carbohydrate content and methods of preparation and use |
| 03/21/1990 | EP0358754A1 Endocrine manipulation to improve body composition of poultry |
| 03/21/1990 | EP0358692A1 Cholera vaccines |
| 03/21/1990 | EP0233206B1 Sugar-containing dipeptides and their pharmaceutical use |
| 03/21/1990 | CN1007267B Process for preparing antibiotic 6270 |
| 03/20/1990 | CA1266860A1 Amphiphile lipidic compositions, process for their preparation and uses, particularly as cosmetics and in dermatology |
| 03/14/1990 | EP0358485A2 Human rhinovirus peptides |
| 03/14/1990 | EP0358468A2 Monoclonal antibody to high molecular weight human epidermal growth factor |
| 03/14/1990 | EP0357856A1 DNA coding for human ventricular myosin light chain 2 |
| 03/14/1990 | EP0357642A1 Vaccine against brucella abortus |
| 03/14/1990 | EP0357622A1 Substituted complex-forming substances, complexes and complex salts, process for manufacture thereof and pharmaceutical agents which contain them |
| 03/14/1990 | EP0200653B1 Hybrid cells producing a hepatitis b virus antigen obtained from hepatocytes and established monkey cells, process for the obtention of these hybrid cells and use thereof in the production of this antigen |
| 03/14/1990 | EP0145783B1 Canine coronavirus vaccine |
| 03/13/1990 | US4908446 Inhibitors of nonenzymatic cross-linking |
| 03/13/1990 | CA1266627A1 Use of a recombinant dna comprising a nucleotide sequence coding for a given polypeptide under the control of an adenovirus promoter |
| 03/08/1990 | WO1990002207A1 Cloned nephritis antigen |
| 03/08/1990 | WO1990002206A1 Detection of non-a, non-b hepatitis |
| 03/08/1990 | WO1990002199A1 Monoclonal antibody for inhibiting cell infection by hiv viruses |
| 03/08/1990 | WO1990002191A1 Recombinant fowlpox virus |
| 03/08/1990 | WO1990002187A1 Recombinant fusion proteins for altering hormone secretion |
| 03/08/1990 | WO1990002186A1 Production of bluetongue virus non-structural proteins using a baculovirus expression vector |
| 03/08/1990 | WO1990002181A1 Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3 |
| 03/08/1990 | WO1990002176A1 Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders |
| 03/08/1990 | WO1990002136A1 Protein derivatives and a process for their preparation |
| 03/08/1990 | WO1990002135A1 Protein derivatives and a process for their preparation |
| 03/08/1990 | WO1990001951A1 Molecular conjugates containing cell membrane-blending agents |
| 03/08/1990 | WO1990001950A1 Pharmaceutical products for anti-neoplastic therapy |
| 03/08/1990 | WO1990001949A1 Gamma inulin compositions |
| 03/08/1990 | WO1990001948A1 Influenza vaccine and novel adjuvants |
| 03/08/1990 | WO1990001947A1 Affinity associated vaccine |
| 03/08/1990 | WO1990001946A1 Recombinant vaccinia virus for prevention of disease caused by flavivirus |
| 03/08/1990 | WO1990001944A1 Legionellosis vaccines and methods for their production |
| 03/08/1990 | WO1990001870A1 Retroviral vectors expressing soluble cd4; a gene therapy for aids |
| 03/07/1990 | EP0357585A2 Preparation active against infections by Pseudomonas aeruginosa, and preparation containing immunoglobulin-G active against Pseudomonas aeruginosa |
| 03/07/1990 | EP0357208A1 Salmonella transformant capable of expression of heterologous genes and useful as a recombinant vaccine |
| 03/07/1990 | EP0357024A2 Dipoprotein I (OMPI) from Pseudomonas aeruginosa |
| 03/07/1990 | EP0356935A2 Inhibition of HIV using transforming growth factor-beta |